SGLT 2 inhibitors: Searching for the best in class
- PMID: 37085120
- DOI: 10.1016/j.ijcard.2023.04.025
SGLT 2 inhibitors: Searching for the best in class
Comment on
-
Cost-effectiveness of dapagliflozin and empagliflozin for treatment of heart failure with reduced ejection fraction.Int J Cardiol. 2023 Apr 1;376:83-89. doi: 10.1016/j.ijcard.2023.01.080. Epub 2023 Feb 2. Int J Cardiol. 2023. PMID: 36736672